GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) was the recipient of a significant increase in short interest in July. As of July 15th, there was short interest totaling 10 shares, an increase of ∞ from the June 30th total of 0 shares. Based on an average daily volume of 53,818 shares, the short-interest ratio is presently 0.0 days.
GB Sciences Price Performance
OTCMKTS GBLX opened at $0.00 on Thursday. GB Sciences has a 12 month low of $0.00 and a 12 month high of $0.01.
About GB Sciences
GB Sciences, Inc is a biotechnology company focused on the research, development and commercialization of cannabinoid-based medicines. Leveraging both botanical and synthetic approaches, the company aims to create novel therapies targeting oncology, neurology and inflammatory diseases. Through its proprietary drug discovery platform, GB Sciences seeks to identify and advance lead compounds that harness the therapeutic potential of cannabinoids while ensuring high standards of quality and safety.
The company operates a cGMP-compliant research and manufacturing facility in Irvine, California, and maintains partnerships to support cultivation and extraction activities in select geographies.
Read More
- Five stocks we like better than GB Sciences
- Palantir’s Earnings Setup Puts Its AI Growth Story Back on Trial Again
- Mining For Megawatts: AMD’s Billion-Dollar Grid Grab
- Circle’s IBM Patent Deal Could Redraw the Stablecoin Infrastructure Race
- Survey Reveals: 62% of US Households Are Cutting Back on Protein as Grocery Prices Rise [2026]
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
